Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome.

ABSTRACT:

Background

Many patients with irritable bowel syndrome (IBS) experience acute and unexpected pain episodes over and above chronic background symptoms, and there are emerging medications designed to treat such pain. We aimed to use conjoint analysis-a technique that elucidates how people make complex decisions-to examine patient preferences for emerging medicines for breakthrough IBS pain.

Methods

We conducted a cross-sectional conjoint analysis survey among patients with Rome IV IBS and recurrent episodes of acute pain to assess the relative importance of medication attributes in their decision-making. We also assessed what respondents would require of subcutaneous (SQ) therapies to consider their use.

Key results

Among 629 patients with Rome IV IBS, 606 (96.3%) repor

SUBMITTER: Almario CV 

PROVIDER: S-EPMC8486892 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature